Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kaas, A, Pfleger, CC, Kharagjitsingh, AV, Schloot, NC, Hansen, L, Buschard, K, Koeleman, BPC, Roep, BO, Mortensen, HB, Alizadeh, BZ & on behalf of the Hvidoere Study Group on Childhood Diabetes 2012, 'Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes' Diabetic Medicine, vol. 29, no. 6, pp. 734-741. https://doi.org/10.1111/j.1464-5491.2011.03544.x

APA

CBE

Kaas A, Pfleger CC, Kharagjitsingh AV, Schloot NC, Hansen L, Buschard K, Koeleman BPC, Roep BO, Mortensen HB, Alizadeh BZ, on behalf of the Hvidoere Study Group on Childhood Diabetes. 2012. Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes. Diabetic Medicine. 29(6):734-741. https://doi.org/10.1111/j.1464-5491.2011.03544.x

MLA

Vancouver

Author

Kaas, A ; Pfleger, Claudia Christina ; Kharagjitsingh, A V ; Schloot, N C ; Hansen, Lars ; Buschard, K ; Koeleman, B P C ; Roep, B O ; Mortensen, H B ; Alizadeh, B Z ; on behalf of the Hvidoere Study Group on Childhood Diabetes. / Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes. In: Diabetic Medicine. 2012 ; Vol. 29, No. 6. pp. 734-741.

Bibtex

@article{2358b25b9e3c4cbbb05f1cbd4793fe02,
title = "Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes",
abstract = "Aims:  The relation of disease progression and age, serum interleukin 10 (IL-10) and interferon gamma (IFNγ) and their genetic correlates were studied in paediatric patients with newly diagnosed Type 1 diabetes. Methods:  Two hundred and twenty-seven patients from the Hvidoere Study Group were classified in four different progression groups as assessed by change in stimulated C-peptide from 1 to 6 months. CA repeat variants of the IL-10 and IFNγ gene were genotyped and serum levels of IL-10 and IFNγ were measured at 1, 6 and 12 months. Results:  IL-10 decreased (P ",
author = "A Kaas and Pfleger, {Claudia Christina} and Kharagjitsingh, {A V} and Schloot, {N C} and Lars Hansen and K Buschard and Koeleman, {B P C} and Roep, {B O} and Mortensen, {H B} and Alizadeh, {B Z} and {on behalf of the Hvidoere Study Group on Childhood Diabetes}",
note = "{\circledC} 2011 The Authors. Diabetic Medicine {\circledC} 2011 Diabetes UK.",
year = "2012",
doi = "10.1111/j.1464-5491.2011.03544.x",
language = "English",
volume = "29",
pages = "734--741",
journal = "Diabet Med",
issn = "0742-3071",
publisher = "Wiley",
number = "6",

}

RIS

TY - JOUR

T1 - Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes

AU - Kaas, A

AU - Pfleger, Claudia Christina

AU - Kharagjitsingh, A V

AU - Schloot, N C

AU - Hansen, Lars

AU - Buschard, K

AU - Koeleman, B P C

AU - Roep, B O

AU - Mortensen, H B

AU - Alizadeh, B Z

AU - on behalf of the Hvidoere Study Group on Childhood Diabetes

N1 - © 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

PY - 2012

Y1 - 2012

N2 - Aims:  The relation of disease progression and age, serum interleukin 10 (IL-10) and interferon gamma (IFNγ) and their genetic correlates were studied in paediatric patients with newly diagnosed Type 1 diabetes. Methods:  Two hundred and twenty-seven patients from the Hvidoere Study Group were classified in four different progression groups as assessed by change in stimulated C-peptide from 1 to 6 months. CA repeat variants of the IL-10 and IFNγ gene were genotyped and serum levels of IL-10 and IFNγ were measured at 1, 6 and 12 months. Results:  IL-10 decreased (P 

AB - Aims:  The relation of disease progression and age, serum interleukin 10 (IL-10) and interferon gamma (IFNγ) and their genetic correlates were studied in paediatric patients with newly diagnosed Type 1 diabetes. Methods:  Two hundred and twenty-seven patients from the Hvidoere Study Group were classified in four different progression groups as assessed by change in stimulated C-peptide from 1 to 6 months. CA repeat variants of the IL-10 and IFNγ gene were genotyped and serum levels of IL-10 and IFNγ were measured at 1, 6 and 12 months. Results:  IL-10 decreased (P 

U2 - 10.1111/j.1464-5491.2011.03544.x

DO - 10.1111/j.1464-5491.2011.03544.x

M3 - Journal article

VL - 29

SP - 734

EP - 741

JO - Diabet Med

JF - Diabet Med

SN - 0742-3071

IS - 6

ER -

ID: 34783259